Robert F. Kennedy Jr.’s push against food and drug companies is reshaping Republican alliances and giving trial lawyers new momentum to challenge corporate power.
WEBDESK – Act Global Media – January 20, 2026
Robert F. Kennedy Jr.’s aggressive campaign against food, chemical, and pharmaceutical companies is reshaping long-standing Republican alliances and opening unexpected common ground between the GOP and the plaintiffs’ bar, a group traditionally viewed as a political adversary.
Kennedy’s agenda, advanced through his Make America Healthy Again movement and amplified by President Donald Trump’s populist approach, has energized trial lawyers who represent consumers alleging corporate harm. From criticism of ultraprocessed foods to attacks on vaccines and pain relievers such as Tylenol, Kennedy’s messaging is increasingly being cited by plaintiffs’ attorneys to support personal injury and mass-tort lawsuits against major corporations.
“The pendulum has swung some in a pro-consumer, pro-plaintiff direction,” said Ashley Keller, founding partner at Keller Postman, whose firm is leading a Texas lawsuit against Johnson & Johnson and Kenvue over Tylenol. The case follows warnings issued last year by the Trump administration and Kennedy cautioning pregnant women about potential risks linked to the drug, based on correlation data.
Business groups that once relied on Republicans to advance tort reform are now reassessing their political strategy. Industry representatives say traditional GOP support for limiting lawsuits has weakened under the Trump-Kennedy partnership. “There are maybe not as many allies for tort reform as there used to be,” said Erica Klenicki, vice president and deputy general counsel for litigation at the National Association of Manufacturers.
Trial lawyers argue that Kennedy’s actions, including removing several childhood vaccines from the routine immunization schedule, could expand litigation by requiring injured patients to sue pharmaceutical companies directly rather than seek compensation through the federal vaccine injury program. Supporters say the shift restores accountability, while critics warn it could increase litigation costs and raise prices for consumers.
Kennedy, a former trial lawyer who won landmark cases against Monsanto and DuPont, has pledged to divest from law firms connected to cases linked to the MAHA movement. However, several firms involved in major mass-tort actions have supported his political efforts and now see momentum building for consumer-focused litigation.
Industry groups accuse the plaintiffs’ bar of driving litigation for profit and spreading misinformation, claims that trial lawyers strongly reject. Attorneys say mass-tort cases are costly, risky and often represent the only way for individuals to challenge large corporations with vast legal and financial resources.
It remains unclear whether the emerging alignment between elements of the GOP and trial lawyers will endure. For now, Kennedy’s agenda is blurring traditional political lines, placing corporate America under increased scrutiny and reshaping the legal and political landscape.
